128 related articles for article (PubMed ID: 34311618)
1. Effects of Social Determinants of Health Care on Pediatric Thyroid Cancer Outcomes in the United States.
Gruszczynski NR; Low CM; Choby G; Meister KD; Smith BH; Balakrishnan K
Otolaryngol Head Neck Surg; 2022 Jun; 166(6):1045-1054. PubMed ID: 34311618
[TBL] [Abstract][Full Text] [Related]
2. MeSS: A novel prognostic scale specific for pediatric well-differentiated thyroid cancer: a population-based, SEER outcomes study.
Shayota BJ; Pawar SC; Chamberlain RS
Surgery; 2013 Sep; 154(3):429-35. PubMed ID: 23972648
[TBL] [Abstract][Full Text] [Related]
3. Pediatric thyroid cancer: An update from the SEER database 2007-2012.
Dermody S; Walls A; Harley EH
Int J Pediatr Otorhinolaryngol; 2016 Oct; 89():121-6. PubMed ID: 27619041
[TBL] [Abstract][Full Text] [Related]
4. Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.
Adam MA; Thomas S; Roman SA; Hyslop T; Sosa JA
JAMA Surg; 2017 Sep; 152(9):869-876. PubMed ID: 28636692
[TBL] [Abstract][Full Text] [Related]
5. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].
Hundahl SA; Fleming ID; Fremgen AM; Menck HR
Cancer; 1998 Dec; 83(12):2638-48. PubMed ID: 9874472
[TBL] [Abstract][Full Text] [Related]
6. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
[TBL] [Abstract][Full Text] [Related]
7. Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer.
Nixon IJ; Kuk D; Wreesmann V; Morris L; Palmer FL; Ganly I; Patel SG; Singh B; Tuttle RM; Shaha AR; Gönen M; Shah JP
Ann Surg Oncol; 2016 Feb; 23(2):410-5. PubMed ID: 26215199
[TBL] [Abstract][Full Text] [Related]
8. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
9. Population-based outcomes for pediatric thyroid carcinoma.
Shapiro NL; Bhattacharyya N
Laryngoscope; 2005 Feb; 115(2):337-40. PubMed ID: 15689762
[TBL] [Abstract][Full Text] [Related]
10. A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry.
Tran Cao HS; Johnston LE; Chang DC; Bouvet M
Surgery; 2012 Aug; 152(2):145-51. PubMed ID: 22503316
[TBL] [Abstract][Full Text] [Related]
11. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
12. Surgically Treated Pediatric Nonpapillary Thyroid Carcinoma.
Golpanian S; Tashiro J; Sola JE; Allen C; Lew JI; Hogan AR; Neville HL; Perez EA
Eur J Pediatr Surg; 2016 Dec; 26(6):524-532. PubMed ID: 26683804
[No Abstract] [Full Text] [Related]
13. Follicular variant papillary thyroid carcinoma in a pediatric population.
Lerner J; Goldfarb M
Pediatr Blood Cancer; 2015 Nov; 62(11):1942-6. PubMed ID: 26131690
[TBL] [Abstract][Full Text] [Related]
14. Social Vulnerability Association with Thyroid Cancer Disparities in the United States.
Fei-Zhang DJ; Verma R; Arimoto R; Lawrence AS; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
Thyroid; 2024 Feb; 34(2):225-233. PubMed ID: 38069566
[No Abstract] [Full Text] [Related]
15. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
[TBL] [Abstract][Full Text] [Related]
16. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
[TBL] [Abstract][Full Text] [Related]
17. Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC).
Gillanders SL; O'Neill JP
Eur J Surg Oncol; 2018 Mar; 44(3):286-296. PubMed ID: 28801060
[TBL] [Abstract][Full Text] [Related]
18. DOES T STAGE AFFECT PROGNOSIS IN PATIENTS WITH STAGE IV B DIFFERENTIATED THYROID CANCER?
Li M; Trivedi N; Dai C; Mao R; Wang Y; Ning Y; Gu SZ; Huo L; Siddiqui AD
Endocr Pract; 2019 Sep; 25(9):877-886. PubMed ID: 31170365
[No Abstract] [Full Text] [Related]
19. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin.
Nilubol N; Zhang L; Kebebew E
Thyroid; 2013 Jun; 23(6):695-702. PubMed ID: 23194434
[TBL] [Abstract][Full Text] [Related]
20. Pediatric Thyroid Microcarcinoma.
Lerner J; Goldfarb M
Ann Surg Oncol; 2015 Dec; 22(13):4187-92. PubMed ID: 25854844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
